Keyphrases
Asthma Call Back Survey
100%
Asthma Action Plan
66%
Sectional Analysis
66%
Public Interest
66%
United States
50%
Children with Asthma
48%
Asthma Treatment
46%
Child Age
41%
Search Interest
40%
Google Trends
37%
Anxiety Prevalence
33%
Peak Flow Meter
33%
Peak Flow
33%
Supervised Injection Facilities
33%
Severe Symptoms
33%
Autoimmune
33%
Clinical Trials
33%
Pediatric
33%
COVID-19
33%
U.S. National Library of Medicine
33%
Survey Results
33%
Childrens
33%
Emergency Room Visits
33%
National Survey
33%
Myocarditis
33%
Trial Discontinuation
33%
Infodemiology
33%
Series Analysis
33%
Candida Auris
33%
Written Asthma Action Plan
30%
Asthma Management
25%
Healthcare Professionals
23%
Urbanicity
23%
Asthma
23%
Disease Prevention
23%
Food Insecurity
22%
Symptom Severity
22%
Anxiety Disorders
22%
Older children
22%
Cognitive Behavioral Therapy
22%
Early Intervention
22%
Chronic Disease
19%
Severe Acute Respiratory Syndrome coronavirus-2 Vaccine
18%
Emergency Room
16%
Overdose Deaths
16%
Philadelphia
16%
Treatment Options
15%
Access to Drugs
15%
Population Prevalence
15%
Symptom Control
15%
Medicine and Dentistry
Asthma
100%
Cross Sectional Study
70%
Drug Therapy
66%
Pediatrics
44%
Prevalence
42%
Peak Expiratory Flow
33%
Clinical Trial
33%
Medicine
33%
Autoimmune Disease
23%
Cognitive Behavioral Therapy
22%
Early Intervention
22%
Anxiety Disorder
22%
COVID-19
22%
Household
22%
Treatment Duration
11%
Child Parent Relation
11%
Mental Health
11%
Mental Disorder
11%
Diagnosis of Anxiety
11%
Post-COVID-19
11%
Linear Regression Analysis
11%
Child Health
11%
Adolescence
11%
Antifungal Therapy
11%
Chronic Disease
8%
Behavioral Risk Factor Surveillance System
7%
Insulin Dependent Diabetes Mellitus
6%
Caspofungin
5%
Ibrexafungerp
5%
Systemic Candidiasis
5%
Rezafungin
5%
Povidone Iodine
5%
Multidrug Resistance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Candida Auris
66%
Cross Sectional Study
66%
Clinical Trial
66%
Toxic Injury
33%
SARS Coronavirus
33%
Myocarditis
33%
Autoimmune Disease
25%
Disease
23%
Prevalence
13%
Infection
13%
Opiate
11%
Chronic Disease
8%
Ibrexafungerp
8%
Multidrug Resistance
8%
Invasive Candidiasis
8%
Povidone-Iodine
8%
Caspofungin
8%
Rezafungin
8%
Adverse Event
8%
Coronavirinae
7%
Insulin Dependent Diabetes Mellitus
7%
